[go: up one dir, main page]

ITMI20060384A1 - Composizioni comprendenti chitosano atte al trattamento terapeutico complessivo o alla prevenzione complessiva della sindrome metabolica - Google Patents

Composizioni comprendenti chitosano atte al trattamento terapeutico complessivo o alla prevenzione complessiva della sindrome metabolica

Info

Publication number
ITMI20060384A1
ITMI20060384A1 IT000384A ITMI20060384A ITMI20060384A1 IT MI20060384 A1 ITMI20060384 A1 IT MI20060384A1 IT 000384 A IT000384 A IT 000384A IT MI20060384 A ITMI20060384 A IT MI20060384A IT MI20060384 A1 ITMI20060384 A1 IT MI20060384A1
Authority
IT
Italy
Prior art keywords
chitosian
activities
therapeutic treatment
metabolic syndrome
compositions including
Prior art date
Application number
IT000384A
Other languages
English (en)
Inventor
Umberto Cornelli
Original Assignee
Umberto Cornelli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Umberto Cornelli filed Critical Umberto Cornelli
Priority to IT000384A priority Critical patent/ITMI20060384A1/it
Priority to EP07726617A priority patent/EP1996207B1/en
Priority to JP2008557733A priority patent/JP5557451B2/ja
Priority to ES07726617T priority patent/ES2392551T3/es
Priority to US12/281,615 priority patent/US9050356B2/en
Priority to PCT/EP2007/052023 priority patent/WO2007099170A1/en
Priority to MX2008011289A priority patent/MX2008011289A/es
Priority to PL07726617T priority patent/PL1996207T3/pl
Publication of ITMI20060384A1 publication Critical patent/ITMI20060384A1/it

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/722—Chitin, chitosan
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L5/00—Compositions of polysaccharides or of their derivatives not provided for in groups C08L1/00 or C08L3/00
    • C08L5/08—Chitin; Chondroitin sulfate; Hyaluronic acid; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Polymers & Plastics (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicinal Preparation (AREA)
IT000384A 2006-03-03 2006-03-03 Composizioni comprendenti chitosano atte al trattamento terapeutico complessivo o alla prevenzione complessiva della sindrome metabolica ITMI20060384A1 (it)

Priority Applications (8)

Application Number Priority Date Filing Date Title
IT000384A ITMI20060384A1 (it) 2006-03-03 2006-03-03 Composizioni comprendenti chitosano atte al trattamento terapeutico complessivo o alla prevenzione complessiva della sindrome metabolica
EP07726617A EP1996207B1 (en) 2006-03-03 2007-03-02 Compositions comprising chitosan suitable for comprehensive therapeutic treatment or comprehensive prevention of the metabolic syndrome
JP2008557733A JP5557451B2 (ja) 2006-03-03 2007-03-02 メタボリック症候群の包括的な治療的処置又は包括的予防に適した、薬物又は補助食品の形態の、キトサンを有する組成物
ES07726617T ES2392551T3 (es) 2006-03-03 2007-03-02 Composiciones que comprenden quitosano adecuadas para el tratamiento terapéutico global o la prevención global de síndrome metabólico
US12/281,615 US9050356B2 (en) 2006-03-03 2007-03-02 Compositions comprising chitosan suitable for comprehensive therapeutic treatment or comprehensive prevention of the metabolic syndrome
PCT/EP2007/052023 WO2007099170A1 (en) 2006-03-03 2007-03-02 Compositions comprising chitosan suitable for comprehensive therapeutic treatment or comprehensive prevention of the metabolic syndrome
MX2008011289A MX2008011289A (es) 2006-03-03 2007-03-02 Composiciones que comprenden quitosano conveniente para tratamiento terapeutico integral o prevencion integral del sindrome metabolico.
PL07726617T PL1996207T3 (pl) 2006-03-03 2007-03-02 Kompozycje zawierające chitozan przydatne do kompleksowego leczenia terapeutycznego lub kompleksowej profilaktyki zespołu metabolicznego

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT000384A ITMI20060384A1 (it) 2006-03-03 2006-03-03 Composizioni comprendenti chitosano atte al trattamento terapeutico complessivo o alla prevenzione complessiva della sindrome metabolica

Publications (1)

Publication Number Publication Date
ITMI20060384A1 true ITMI20060384A1 (it) 2007-09-04

Family

ID=38019452

Family Applications (1)

Application Number Title Priority Date Filing Date
IT000384A ITMI20060384A1 (it) 2006-03-03 2006-03-03 Composizioni comprendenti chitosano atte al trattamento terapeutico complessivo o alla prevenzione complessiva della sindrome metabolica

Country Status (8)

Country Link
US (1) US9050356B2 (it)
EP (1) EP1996207B1 (it)
JP (1) JP5557451B2 (it)
ES (1) ES2392551T3 (it)
IT (1) ITMI20060384A1 (it)
MX (1) MX2008011289A (it)
PL (1) PL1996207T3 (it)
WO (1) WO2007099170A1 (it)

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS54148090A (en) 1978-05-11 1979-11-19 Ajinomoto Co Inc Peroral cholesterol-depressant
US4223023A (en) * 1978-10-12 1980-09-16 Ivan Furda Nonabsorbable lipid binder
JP2614297B2 (ja) * 1988-12-27 1997-05-28 三栄源エフ・エフ・アイ株式会社 ソーマチンの凝集・分離防止及び甘味改善法
JPH04108734A (ja) 1990-08-29 1992-04-09 Kurita Water Ind Ltd 降コレステロール剤
JP2667351B2 (ja) * 1992-03-24 1997-10-27 麒麟麦酒株式会社 食餌脂質消化吸収阻害剤および飲食品
JP2507907B2 (ja) 1992-06-08 1996-06-19 水産庁長官 血圧降下用の食品添加物質および抗高血圧剤
US5550019A (en) * 1993-05-26 1996-08-27 La Jolla Cancer Research Foundation Methods of identifying compounds which alter apoptosis
US6180148B1 (en) * 1996-05-28 2001-01-30 Asama Chemical Co., Ltd. Method for cooking fresh noodles in a microwave oven
US20030069206A1 (en) 1998-07-10 2003-04-10 Nichols Everett J. Methods and kits for absorbing fat
DE69916288T2 (de) * 1998-08-14 2005-03-24 F. Hoffmann-La Roche Ag Lipasehemmer und chitosan enthaltende arzneimittel
JP3371843B2 (ja) 1999-02-25 2003-01-27 扶桑化学工業株式会社 ロングライフ麺およびその製造方法
US20020016307A1 (en) * 1999-10-27 2002-02-07 Mullins John Jason Gentry Pharmaceutical composition with both a lipase inhibitor and a lipophilic polysaccharide and an improved method for treating adiposity
DE10054450A1 (de) 2000-09-06 2002-03-28 Guillermo Pasch Alonso Verfahren zur Modifikation von Getreidemahlerzeugnissen, nach dem Verfahren hergestellte Produkte und deren Verwendung
JP5024807B2 (ja) 2001-03-21 2012-09-12 独立行政法人水産総合研究センター 血圧上昇の抑制組成物
JP2003113089A (ja) * 2001-10-04 2003-04-18 Gotoo Corporation:Kk 脂質蓄積性阻害およびコレステロール低下作用を有するキトサン含有製剤および飲食品
JP2003238602A (ja) 2002-02-20 2003-08-27 Marino Forum 21 血糖値上昇抑制性物質
ITRM20030127A1 (it) 2003-03-24 2004-09-25 Osvaldo Legnini Composizione alimentare, pasta alimentare funzionale
KR100520007B1 (ko) * 2003-05-19 2005-10-11 건 식 조 혈압 강하 기능을 가지는 키토산 함유 소금의 제조방법
NZ549535A (en) * 2004-03-17 2010-11-26 Novartis Ag Use of aliskiren for treating renal and other disorders
CN1692782A (zh) * 2005-06-26 2005-11-09 苟春虎 降压好酸奶片
RU2290185C1 (ru) 2005-07-26 2006-12-27 Дмитрий Николаевич Мясников Композиция для нормализации липидного обмена и снижения массы тела и способ её получения

Also Published As

Publication number Publication date
MX2008011289A (es) 2009-01-27
ES2392551T3 (es) 2012-12-11
PL1996207T3 (pl) 2013-01-31
JP5557451B2 (ja) 2014-07-23
US9050356B2 (en) 2015-06-09
EP1996207B1 (en) 2012-08-08
EP1996207A1 (en) 2008-12-03
JP2009531306A (ja) 2009-09-03
WO2007099170A1 (en) 2007-09-07
US20090258839A1 (en) 2009-10-15

Similar Documents

Publication Publication Date Title
EP2068864A4 (en) THERAPEUTIC USES OF UROLITHINES
DK2185164T3 (da) Sammensætning og terapeutisk antitumorvaccine
EP2154969A4 (en) TREATMENT OF SYNNUCLEOPATHY
DK2474321T3 (da) Sammensætninger til behandling af collagenmedierede sygdomme
EP1744751A4 (en) METHOD FOR THE TREATMENT OF SYNUCLEINOPATHIES
PL3167888T3 (pl) Leczenie pacjentów z napadową nocną hemoglobinurią za pomocą inhibitora dopełniacza
EP2056673A4 (en) COMBINATION TREATMENT FOR METABOLISM DISEASES
EP2051760A4 (en) ADMINISTRATION OF ANTI-THERAPY
PL3354276T3 (pl) Kompozycje do leczenia zapalenia przewodu pokarmowego
PT2448582T (pt) Compostos e composições terapêuticas
ZA200803659B (en) Use of complement pathway inhibitors to treat ocular disease
SI2056807T1 (sl) Zdravljenje vnetnih bolezni
CY2014030I1 (el) Θεραπευτικες συνθεσεις που περιλαμβανουν ingenol-3-angelate
EP2046349A4 (en) TREATMENT OF EXCESSIVE NEOVASCULARIZATION
EP2338519A4 (en) MEANS FOR THE TREATMENT OF MYELOFIBROSIS
ATE530175T1 (de) Therapeutische kombination für schmerzhafte medizinische zustände
PT2046324T (pt) Tratamento e prevenção de mucosite por derivados de antocianidina
EP2001461A4 (en) COMBINATION TREATMENT FOR METABOLISM DISEASES
ZA200806808B (en) Treatment of stressed patients
EP2247297A4 (en) THERAPEUTIC TREATMENT OF LUNG DISEASES
EP2023950A4 (en) CANCER TREATMENT WITH URODILATIN
HRP20150052T1 (xx) Fungicidni pripravak i postupak za suzbijanje bolesti biljaka
DK2063881T3 (da) Sammensætning og fremgangsmåde til virksom og sikker administration af halopyruvat til behandlingen af cancer
EP1962839A4 (en) ADMINISTRATION OF A MNTOR INHIBITOR FOR THE TREATMENT OF PATIENTS WITH CANCER
FI20095600L (fi) Koostumus ihosairauksien hoitoa varten